The success of the Human Genome Project resulted in the generation of large volumes of genomic data, which is extensively used in biotechnology and medical research. Further, advancements in high throughput gene sequencing technologies have enabled scientists to expedite the genome sequencing process, and achieve significant cost benefits as well. In fact, it is estimated that, by 2025, around 15% of the world's population will have had their genomes sequenced, resulting in the generation of several zettabytes of data.
However, currently, there are not many reliable and secure data management resources that offer secure storage, seamless exchange of information, and a reliable transaction platform, for large volumes of genomic and clinical data. Therefore, at this stage, it has become important to develop and establish the necessary tools and technologies to effectively help with the processing and analysis of the aforementioned information and for making it easily accessible to practicing physicians, scientists, pharmaceutical companies and other stakeholders.
The blockchain technology has emerged as a viable option to store/exchange genomic data. The decentralized information management model used in blockchains has demonstrated significant benefits in banking and the fintech industry. Moreover, cryptocurrencies, which are based on the blockchain technology, are considered to be a powerful tool for peer-to-peer transactions without involving a third party to track the exchange.
In the field of genomics, blockchain can act as a trusted means of carrying out transactions between data owners and data users (research groups/pharmaceutical companies). Moreover, such platforms enable easy access to genomic datasets, thereby, significantly improving the information procurement process for research studies related to personalized drugs/therapies.
As a result, many companies have undertaken initiatives to promote the use of blockchain technology for genomic data management. In fact, the growing importance of blockchain for managing genetic information and using it in healthcare decision-making is also evident in the number of tweets (~1,750) posted on the social media platform, Twitter, in the recent years.
In the past few years, recent activities in this domain, such as the establishment of strategic partnerships (involving pharmaceutical players and relevant government bodies) and investments by venture capital/other stakeholders, indicate that the concept of using blockchain platforms for the storage and management of genetic information is gaining traction in the healthcare industry. We believe that such efforts are likely to boost the overall growth of this market in the coming years.
Key Topics Covered
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Profiles
6. Emerging Trends On Social Media
7. Stakeholder Needs Analysis
8. Go-To-Market Strategy
9. Market Capitalization Analysis
10. Blockchain in Genomic Data Management Use Cases and Opportunity Assessment
11. Recent Trends Analysis
12. Executive Insights
Companies Featured
- 23andMe
- Ancestry
- Anorak Ventures
- ARCH Venture Partners
- BIGSTER
- Biologix Group
- Block23
- Boost VC
- Bridge Link Capital
- eMQT
- Emrify
- EncrypGen
- Enigma Technologies
- Fenbushi Capital
- Gene BlockChain
- Genomes.io
- Health Wizz
- Heartbeat Labs
- Hemi Ventures
- Hemisphere Ventures
- Hikma Ventures
- Hoperidge Capital
- Illumina Ventures
- Ironside Capital
- Khosla Ventures
- Longenesis
- Nebula Genomics
- Shivom
- SimplyVital Health
- SingularityNET
- Spherity
- X Genomics
- YEI Innovation Fund
- Zenome
-
and many more...
For more information about this report visit https://www.researchandmarkets.com/research/5kmdk5/blockchain_in?w=4
